EVLO

Evelo Biosciences (EVLO)

Evelo Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:EVLO

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/01/27	07:30	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NASDAQ:EVLO	Evelo Biosciences Inc
2024/01/27	07:29	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:EVLO	Evelo Biosciences Inc
2024/01/27	07:28	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:EVLO	Evelo Biosciences Inc
2024/01/27	07:27	Edgar (US Regulatory)	Form POS AM - Post-Effective amendments for registration statement	NASDAQ:EVLO	Evelo Biosciences Inc
2024/01/27	07:26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVLO	Evelo Biosciences Inc
2023/12/12	21:43	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:EVLO	Evelo Biosciences Inc
2023/12/12	21:42	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:EVLO	Evelo Biosciences Inc
2023/12/04	20:04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVLO	Evelo Biosciences Inc
2023/12/01	21:11	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:EVLO	Evelo Biosciences Inc
2023/11/21	20:44	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVLO	Evelo Biosciences Inc
2023/11/10	07:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EVLO	Evelo Biosciences Inc
2023/11/09	10:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVLO	Evelo Biosciences Inc
2023/11/09	10:32	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVLO	Evelo Biosciences Inc
2023/11/09	10:31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVLO	Evelo Biosciences Inc
2023/11/04	05:12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVLO	Evelo Biosciences Inc
2023/11/04	05:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVLO	Evelo Biosciences Inc
2023/11/04	05:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVLO	Evelo Biosciences Inc
2023/10/28	06:24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVLO	Evelo Biosciences Inc
2023/10/17	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVLO	Evelo Biosciences Inc
2023/10/17	20:00	GlobeNewswire Inc.	Evelo Biosciences Announces Top-Line Results From its Phase 2 Clinical Study with EDP2939 in Moderate Psoriasis	NASDAQ:EVLO	Evelo Biosciences Inc
2023/09/14	09:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVLO	Evelo Biosciences Inc
2023/09/14	09:55	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVLO	Evelo Biosciences Inc
2023/09/14	09:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:EVLO	Evelo Biosciences Inc
2023/08/22	06:25	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:EVLO	Evelo Biosciences Inc
2023/08/22	06:25	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:EVLO	Evelo Biosciences Inc
2023/08/21	20:43	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVLO	Evelo Biosciences Inc
2023/08/18	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:EVLO	Evelo Biosciences Inc
2023/08/14	21:14	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:EVLO	Evelo Biosciences Inc
2023/08/14	20:42	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:EVLO	Evelo Biosciences Inc
2023/08/14	20:30	GlobeNewswire Inc.	Evelo Biosciences Announces Second Quarter Financial Results and Recent Business Highlights	NASDAQ:EVLO	Evelo Biosciences Inc